Cell factories for insulin production

NA Baeshen, MN Baeshen, A Sheikh, RS Bora… - Microbial cell …, 2014 - Springer
The rapid increase in the number of diabetic patients globally and exploration of alternate
insulin delivery methods such as inhalation or oral route that rely on higher doses, is bound …

Microbial cellulose utilization: fundamentals and biotechnology

LR Lynd, PJ Weimer, WH Van Zyl… - … and molecular biology …, 2002 - Am Soc Microbiol
Fundamental features of microbial cellulose utilization are examined at successively higher
levels of aggregation encompassing the structure and composition of cellulosic biomass …

Molecular engineering of insulin icodec, the first acylated insulin analog for once-weekly administration in humans

TB Kjeldsen, F Hubalek, CU Hjørringgaard… - Journal of Medicinal …, 2021 - ACS Publications
Here, we describe the molecular engineering of insulin icodec to achieve a plasma half-life
of 196 h in humans, suitable for once-weekly subcutaneously administration. Insulin icodec …

Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing

E Nishimura, L Pridal, T Glendorf, BF Hansen… - BMJ Open Diabetes …, 2021 - drc.bmj.com
Introduction Insulin icodec is a novel, long-acting insulin analog designed to cover basal
insulin requirements with once-weekly subcutaneous administration. Here we describe the …

Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development

N Zhao, Y Song, X Xie, Z Zhu, C Duan… - … and Targeted Therapy, 2023 - nature.com
The fast-developing synthetic biology (SB) has provided many genetic tools to reprogram
and engineer cells for improved performance, novel functions, and diverse applications …

Recombinant expression systems in the pharmaceutical industry

FR Schmidt - Applied microbiology and biotechnology, 2004 - Springer
In terms of downstream processing efficiency, secretory expression systems offer potential
advantages for the production of recombinant proteins, compared with inclusion body …

Metabolic engineering of recombinant protein secretion by Saccharomyces cerevisiae

J Hou, KEJ Tyo, Z Liu, D Petranovic… - FEMS Yeast …, 2012 - academic.oup.com
The yeast Saccharomyces cerevisiae is a widely used cell factory for the production of fuels
and chemicals, and it is also provides a platform for the production of many heterologous …

Bacterial inclusion bodies: discovering their better half

U Rinas, E Garcia-Fruitós, JL Corchero… - Trends in biochemical …, 2017 - cell.com
Bacterial inclusion bodies (IBs) are functional, non-toxic amyloids occurring in recombinant
bacteria showing analogies with secretory granules of the mammalian endocrine system …

Insulin structure and function

JP Mayer, F Zhang, RD DiMarchi - Peptide Science: Original …, 2007 - Wiley Online Library
Throughout much of the last century insulin served a central role in the advancement of
peptide chemistry, pharmacology, cell signaling and structural biology. These discoveries …

Production of recombinant proteins: challenges and solutions

LA Palomares, S Estrada-Moncada… - … gene expression: reviews …, 2004 - Springer
Efficient strategies for the production of recombinant proteins are gaining increasing
importance, as more applications that require high amounts of high-quality proteins reach …